Global Opioids Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Opioids Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Opioids Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Market Segment by Application
1.3.1 Global Opioids Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Opioids Market Size (2017-2028)
2.1.1 Global Opioids Revenue (2017-2028)
2.1.2 Global Opioids Sales (2017-2028)
2.2 Global Opioids Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Opioids Sales by Regions (2017-2022)
2.2.2 Global Opioids Revenue by Regions (2017-2022)
2.3 Global Opioids Market Size Forecast by Region
2.3.1 Global Opioids Sales Forecast by Region (2023-2028)
2.3.2 Global Opioids Revenue Forecast by Region (2023-2028)
2.4 Global Top Opioids Regions (Countries) Ranking by Market Size
2.5 Opioids Market Dynamics
2.5.1 Opioids Market Trends
2.5.2 Opioids Market Drivers
2.5.3 Opioids Market Challenges
2.5.4 Opioids Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Opioids Manufacturers by Sales (2017-2022)
3.1.1 Global Opioids Sales by Manufacturers (2017-2022)
3.1.2 Global Opioids Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Opioids Sales in 2021
3.2 Global Top Manufacturers Opioids by Revenue
3.2.1 Global Opioids Revenue by Manufacturers (2017-2022)
3.2.2 Top Opioids Manufacturers Covered: Ranking by Revenue
3.2.3 Global Opioids Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Opioids Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids as of 2021)
3.4 Global Opioids Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Opioids Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Opioids Market
3.7 Key Manufacturers Opioids Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Opioids Market Size by Type
4.1 Global Opioids Historic Market Review by Type (2017-2022)
4.1.1 Global Opioids Sales Market Share by Type (2017-2022)
4.1.2 Global Opioids Revenue Market Share by Type (2017-2022)
4.1.3 Opioids Price by Type (2017-2022)
4.2 Global Opioids Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Opioids Sales Forecast by Type (2023-2028)
4.2.2 Global Opioids Revenue Forecast by Type (2023-2028)
4.2.3 Opioids Price Forecast by Type (2023-2028)
5 Global Opioids Market Size by Application
5.1 Global Opioids Historic Market Review by Application (2017-2022)
5.1.1 Global Opioids Sales Market Share by Application (2017-2022)
5.1.2 Global Opioids Revenue Market Share by Application (2017-2022)
5.1.3 Opioids Price by Application (2017-2022)
5.2 Global Opioids Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Opioids Sales Forecast by Application (2023-2028)
5.2.2 Global Opioids Revenue Forecast by Application (2023-2028)
5.2.3 Opioids Price Forecast by Application (2023-2028)
6 North America
6.1 North America Opioids Sales Breakdown by Company
6.1.1 North America Opioids Sales by Company (2017-2022)
6.1.2 North America Opioids Revenue by Company (2017-2022)
6.2 North America Opioids Market Size by Type
6.2.1 North America Opioids Sales by Type (2017-2028)
6.2.2 North America Opioids Revenue by Type (2017-2028)
6.3 North America Opioids Market Size by Application
6.3.1 North America Opioids Sales by Application (2017-2028)
6.3.2 North America Opioids Revenue by Application (2017-2028)
6.4 North America Opioids Market Size by Country
6.4.1 North America Opioids Sales by Country (2017-2028)
6.4.2 North America Opioids Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Opioids Sales Breakdown by Company
7.1.1 Europe Opioids Sales by Company (2017-2022)
7.1.2 Europe Opioids Revenue by Company (2017-2022)
7.2 Europe Opioids Market Size by Type
7.2.1 Europe Opioids Sales by Type (2017-2028)
7.2.2 Europe Opioids Revenue by Type (2017-2028)
7.3 Europe Opioids Market Size by Application
7.3.1 Europe Opioids Sales by Application (2017-2028)
7.3.2 Europe Opioids Revenue by Application (2017-2028)
7.4 Europe Opioids Market Size by Country
7.4.1 Europe Opioids Sales by Country (2017-2028)
7.4.2 Europe Opioids Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Opioids Sales Breakdown by Company
8.1.1 Asia Pacific Opioids Sales by Company (2017-2022)
8.1.2 Asia Pacific Opioids Revenue by Company (2017-2022)
8.2 Asia Pacific Opioids Market Size by Type
8.2.1 Asia Pacific Opioids Sales by Type (2017-2028)
8.2.2 Asia Pacific Opioids Revenue by Type (2017-2028)
8.3 Asia Pacific Opioids Market Size by Application
8.3.1 Asia Pacific Opioids Sales by Application (2017-2028)
8.3.2 Asia Pacific Opioids Revenue by Application (2017-2028)
8.4 Asia Pacific Opioids Market Size by Region
8.4.1 Asia Pacific Opioids Sales by Region
8.4.2 Asia Pacific Opioids Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Opioids Sales Breakdown by Company
9.1.1 Latin America Opioids Sales by Company (2017-2022)
9.1.2 Latin America Opioids Revenue by Company (2017-2022)
9.2 Latin America Opioids Market Size by Type
9.2.1 Latin America Opioids Sales by Type (2017-2028)
9.2.2 Latin America Opioids Revenue by Type (2017-2028)
9.3 Latin America Opioids Market Size by Application
9.3.1 Latin America Opioids Sales by Application (2017-2028)
9.3.2 Latin America Opioids Revenue by Application (2017-2028)
9.4 Latin America Opioids Market Size by Country
9.4.1 Latin America Opioids Sales by Country (2017-2028)
9.4.2 Latin America Opioids Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Opioids Sales Breakdown by Company
10.1.1 Middle East and Africa Opioids Sales by Company (2017-2022)
10.1.2 Middle East and Africa Opioids Revenue by Company (2017-2022)
10.2 Middle East and Africa Opioids Market Size by Type
10.2.1 Middle East and Africa Opioids Sales by Type (2017-2028)
10.2.2 Middle East and Africa Opioids Revenue by Type (2017-2028)
10.3 Middle East and Africa Opioids Market Size by Application
10.3.1 Middle East and Africa Opioids Sales by Application (2017-2028)
10.3.2 Middle East and Africa Opioids Revenue by Application (2017-2028)
10.4 Middle East and Africa Opioids Market Size by Country
10.4.1 Middle East and Africa Opioids Sales by Country (2017-2028)
10.4.2 Middle East and Africa Opioids Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Teva Opioids Products and Services
11.1.5 Teva Opioids SWOT Analysis
11.1.6 Teva Recent Developments
11.2 Purdue Pharma
11.2.1 Purdue Pharma Corporation Information
11.2.2 Purdue Pharma Overview
11.2.3 Purdue Pharma Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Purdue Pharma Opioids Products and Services
11.2.5 Purdue Pharma Opioids SWOT Analysis
11.2.6 Purdue Pharma Recent Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Corporation Information
11.3.2 Mallinckrodt Overview
11.3.3 Mallinckrodt Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Mallinckrodt Opioids Products and Services
11.3.5 Mallinckrodt Opioids SWOT Analysis
11.3.6 Mallinckrodt Recent Developments
11.4 Amneal Pharma
11.4.1 Amneal Pharma Corporation Information
11.4.2 Amneal Pharma Overview
11.4.3 Amneal Pharma Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Amneal Pharma Opioids Products and Services
11.4.5 Amneal Pharma Opioids SWOT Analysis
11.4.6 Amneal Pharma Recent Developments
11.5 Collegium
11.5.1 Collegium Corporation Information
11.5.2 Collegium Overview
11.5.3 Collegium Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Collegium Opioids Products and Services
11.5.5 Collegium Opioids SWOT Analysis
11.5.6 Collegium Recent Developments
11.6 J&J
11.6.1 J&J Corporation Information
11.6.2 J&J Overview
11.6.3 J&J Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 J&J Opioids Products and Services
11.6.5 J&J Opioids SWOT Analysis
11.6.6 J&J Recent Developments
11.7 Endo
11.7.1 Endo Corporation Information
11.7.2 Endo Overview
11.7.3 Endo Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Endo Opioids Products and Services
11.7.5 Endo Opioids SWOT Analysis
11.7.6 Endo Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Pfizer Opioids Products and Services
11.8.5 Pfizer Opioids SWOT Analysis
11.8.6 Pfizer Recent Developments
11.9 INSYS
11.9.1 INSYS Corporation Information
11.9.2 INSYS Overview
11.9.3 INSYS Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 INSYS Opioids Products and Services
11.9.5 INSYS Opioids SWOT Analysis
11.9.6 INSYS Recent Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Overview
11.10.3 Mylan Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Mylan Opioids Products and Services
11.10.5 Mylan Opioids SWOT Analysis
11.10.6 Mylan Recent Developments
11.11 Hikma
11.11.1 Hikma Corporation Information
11.11.2 Hikma Overview
11.11.3 Hikma Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Hikma Opioids Products and Services
11.11.5 Hikma Recent Developments
11.12 Egalet
11.12.1 Egalet Corporation Information
11.12.2 Egalet Overview
11.12.3 Egalet Opioids Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Egalet Opioids Products and Services
11.12.5 Egalet Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Opioids Value Chain Analysis
12.2 Opioids Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Opioids Production Mode & Process
12.4 Opioids Sales and Marketing
12.4.1 Opioids Sales Channels
12.4.2 Opioids Distributors
12.5 Opioids Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Opioids Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oxycodone
Table 3. Major Manufacturers of Hydromorphone
Table 4. Major Manufacturers of Codeine
Table 5. Major Manufacturers of Fentanyl
Table 6. Major Manufacturers of Other
Table 7. Global Opioids Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Opioids Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Opioids Sales by Region (2017-2022) & (MT)
Table 10. Global Opioids Sales Market Share by Region (2017-2022)
Table 11. Global Opioids Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Opioids Revenue Market Share by Region (2017-2022)
Table 13. Global Opioids Sales Forecast by Region (2023-2028) & (MT)
Table 14. Global Opioids Sales Market Share Forecast by Region (2023-2028)
Table 15. Global Opioids Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 16. Global Opioids Revenue Market Share Forecast by Region (2023-2028)
Table 17. Top Opioids Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 18. Opioids Market Trends
Table 19. Opioids Market Drivers
Table 20. Opioids Market Challenges
Table 21. Opioids Market Restraints
Table 22. Global Opioids Sales by Manufacturers (2017-2022) & (MT)
Table 23. Global Opioids Sales Share by Manufacturers (2017-2022)
Table 24. Global Opioids Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Ranking of Global Top Opioids Manufacturers by Revenue (US$ Million) in 2021
Table 26. Opioids Revenue Share by Manufacturers (2017-2022)
Table 27. Global Opioids Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids as of 2021)
Table 29. Key Manufacturers Opioids Average Selling Price (ASP) & (2017-2022) & (USD/Kg)
Table 30. Key Manufacturers Opioids Plants/Factories Distribution
Table 31. Key Manufacturers Opioids Area Served
Table 32. Date of Key Manufacturers Enter into Opioids Market
Table 33. Key Manufacturers Opioids Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Opioids Sales (MT) by Type (2017-2022)
Table 36. Global Opioids Sales Share by Type (2017-2022)
Table 37. Global Opioids Revenue (US$ Million) Market Share by Type (2017-2022)
Table 38. Global Opioids Price (MT) by Type (2017-2022)
Table 39. Global Opioids Sales (MT) by Type (2023-2028)
Table 40. Global Opioids Sales Share by Type (2023-2028)
Table 41. Global Opioids Revenue (US$ Million) Market Share by Type (2023-2028)
Table 42. Global Opioids Revenue Share by Type (2023-2028)
Table 43. Global Opioids Price (MT) by Type (2023-2028)
Table 44. Global Opioids Sales (MT) by Application (2017-2022)
Table 45. Global Opioids Sales Share by Application (2017-2022)
Table 46. Global Opioids Revenue (US$ Million) Market Share by Application (2017-2022)
Table 47. Global Opioids Price (MT) by Application (2017-2022)
Table 48. Global Opioids Sales (MT) by Application (2023-2028)
Table 49. Global Opioids Sales Share by Application (2023-2028)
Table 50. Global Opioids Revenue (US$ Million) Market Share by Application (2023-2028)
Table 51. Global Opioids Revenue Share by Application (2023-2028)
Table 52. Global Opioids Price (MT) by Application (2023-2028)
Table 53. North America Opioids Sales by Company (2017-2022) & (MT)
Table 54. North America Opioids Sales Market Share by Company (2017-2022)
Table 55. North America Opioids Revenue by Company (2017-2022) & (US$ Million)
Table 56. North America Opioids Revenue Market Share by Company (2017-2022)
Table 57. North America Opioids Sales by Type (2017-2022) & (MT)
Table 58. North America Opioids Sales by Type (2023-2028) & (MT)
Table 59. North America Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 60. North America Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 61. North America Opioids Sales by Application (2017-2022) & (MT)
Table 62. North America Opioids Sales by Application (2023-2028) & (MT)
Table 63. North America Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 64. North America Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 65. North America Opioids Sales by Country (2017-2022) & (MT)
Table 66. North America Opioids Sales by Country (2023-2028) & (MT)
Table 67. North America Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 68. North America Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 69. Europe Opioids Sales by Company (2017-2022) & (MT)
Table 70. Europe Opioids Sales Market Share by Company (2017-2022)
Table 71. Europe Opioids Revenue by Company (2017-2022) & (US$ Million)
Table 72. Europe Opioids Revenue Market Share by Company (2017-2022)
Table 73. Europe Opioids Sales by Type (2017-2022) & (MT)
Table 74. Europe Opioids Sales by Type (2023-2028) & (MT)
Table 75. Europe Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 76. Europe Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 77. Europe Opioids Sales by Application (2017-2022) & (MT)
Table 78. Europe Opioids Sales by Application (2023-2028) & (MT)
Table 79. Europe Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 80. Europe Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 81. Europe Opioids Sales by Country (2017-2022) & (MT)
Table 82. Europe Opioids Sales by Country (2023-2028) & (MT)
Table 83. Europe Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 84. Europe Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 85. Asia Pacific Opioids Sales by Company (2017-2022) & (MT)
Table 86. Asia Pacific Opioids Sales Market Share by Company (2017-2022)
Table 87. Asia Pacific Opioids Revenue by Company (2017-2022) & (US$ Million)
Table 88. Asia Pacific Opioids Revenue Market Share by Company (2017-2022)
Table 89. Asia Pacific Opioids Sales by Type (2017-2022) & (MT)
Table 90. Asia Pacific Opioids Sales by Type (2023-2028) & (MT)
Table 91. Asia Pacific Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 92. Asia Pacific Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 93. Asia Pacific Opioids Sales by Application (2017-2022) & (MT)
Table 94. Asia Pacific Opioids Sales by Application (2023-2028) & (MT)
Table 95. Asia Pacific Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 96. Asia Pacific Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 97. Asia Pacific Opioids Sales by Region (2017-2022) & (MT)
Table 98. Asia Pacific Opioids Sales by Region (2023-2028) & (MT)
Table 99. Asia Pacific Opioids Revenue by Region (2017-2022) & (US$ Million)
Table 100. Asia Pacific Opioids Revenue by Region (2023-2028) & (US$ Million)
Table 101. Latin America Opioids Sales by Company (2017-2022) & (MT)
Table 102. Latin America Opioids Sales Market Share by Company (2017-2022)
Table 103. Latin America Opioids Revenue by Company (2017-2022) & (US$ Million)
Table 104. Latin America Opioids Revenue Market Share by Company (2017-2022)
Table 105. Latin America Opioids Sales by Type (2017-2022) & (MT)
Table 106. Latin America Opioids Sales by Type (2023-2028) & (MT)
Table 107. Latin America Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 108. Latin America Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 109. Latin America Opioids Sales by Application (2017-2022) & (MT)
Table 110. Latin America Opioids Sales by Application (2023-2028) & (MT)
Table 111. Latin America Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 112. Latin America Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 113. Latin America Opioids Sales by Country (2017-2022) & (MT)
Table 114. Latin America Opioids Sales by Country (2023-2028) & (MT)
Table 115. Latin America Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 116. Latin America Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 117. Middle East and Africa Opioids Sales by Company (2017-2022) & (MT)
Table 118. Middle East and Africa Opioids Sales Market Share by Company (2017-2022)
Table 119. Middle East and Africa Opioids Revenue by Company (2017-2022) & (US$ Million)
Table 120. Middle East and Africa Opioids Revenue Market Share by Company (2017-2022)
Table 121. Middle East and Africa Opioids Sales by Type (2017-2022) & (MT)
Table 122. Middle East and Africa Opioids Sales by Type (2023-2028) & (MT)
Table 123. Middle East and Africa Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 124. Middle East and Africa Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 125. Middle East and Africa Opioids Sales by Application (2017-2022) & (MT)
Table 126. Middle East and Africa Opioids Sales by Application (2023-2028) & (MT)
Table 127. Middle East and Africa Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 128. Middle East and Africa Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 129. Middle East and Africa Opioids Sales by Country (2017-2022) & (MT)
Table 130. Middle East and Africa Opioids Sales by Country (2023-2028) & (MT)
Table 131. Middle East and Africa Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 132. Middle East and Africa Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 133. Teva Corporation Information
Table 134. Teva Description and Overview
Table 135. Teva Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 136. Teva Opioids Product and Services
Table 137. Teva Opioids SWOT Analysis
Table 138. Teva Recent Developments
Table 139. Purdue Pharma Corporation Information
Table 140. Purdue Pharma Description and Overview
Table 141. Purdue Pharma Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 142. Purdue Pharma Opioids Product and Services
Table 143. Purdue Pharma Opioids SWOT Analysis
Table 144. Purdue Pharma Recent Developments
Table 145. Mallinckrodt Corporation Information
Table 146. Mallinckrodt Description and Overview
Table 147. Mallinckrodt Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 148. Mallinckrodt Opioids Product and Services
Table 149. Mallinckrodt Opioids SWOT Analysis
Table 150. Mallinckrodt Recent Developments
Table 151. Amneal Pharma Corporation Information
Table 152. Amneal Pharma Description and Overview
Table 153. Amneal Pharma Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 154. Amneal Pharma Opioids Product and Services
Table 155. Amneal Pharma Opioids SWOT Analysis
Table 156. Amneal Pharma Recent Developments
Table 157. Collegium Corporation Information
Table 158. Collegium Description and Overview
Table 159. Collegium Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 160. Collegium Opioids Product and Services
Table 161. Collegium Opioids SWOT Analysis
Table 162. Collegium Recent Developments
Table 163. J&J Corporation Information
Table 164. J&J Description and Overview
Table 165. J&J Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 166. J&J Opioids Product and Services
Table 167. J&J Opioids SWOT Analysis
Table 168. J&J Recent Developments
Table 169. Endo Corporation Information
Table 170. Endo Description and Overview
Table 171. Endo Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 172. Endo Opioids Product and Services
Table 173. Endo Opioids SWOT Analysis
Table 174. Endo Recent Developments
Table 175. Pfizer Corporation Information
Table 176. Pfizer Description and Overview
Table 177. Pfizer Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 178. Pfizer Opioids Product and Services
Table 179. Pfizer Opioids SWOT Analysis
Table 180. Pfizer Recent Developments
Table 181. INSYS Corporation Information
Table 182. INSYS Description and Overview
Table 183. INSYS Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 184. INSYS Opioids Product and Services
Table 185. INSYS Opioids SWOT Analysis
Table 186. INSYS Recent Developments
Table 187. Mylan Corporation Information
Table 188. Mylan Description and Overview
Table 189. Mylan Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 190. Mylan Opioids Product and Services
Table 191. Mylan Opioids SWOT Analysis
Table 192. Mylan Recent Developments
Table 193. Hikma Corporation Information
Table 194. Hikma Description and Overview
Table 195. Hikma Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 196. Hikma Opioids Product and Services
Table 197. Hikma Recent Developments
Table 198. Egalet Corporation Information
Table 199. Egalet Description and Overview
Table 200. Egalet Opioids Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2017-2022)
Table 201. Egalet Opioids Product and Services
Table 202. Egalet Recent Developments
Table 203. Key Raw Materials Lists
Table 204. Raw Materials Key Suppliers Lists
Table 205. Opioids Distributors List
Table 206. Opioids Customers List
Table 207. Research Programs/Design for This Report
Table 208. Key Data Information from Secondary Sources
Table 209. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Product Picture
Figure 2. Global Opioids Sales Market Share by Type in 2021 & 2028
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Other Product Picture
Figure 8. Global Opioids Sales Market Share by Application in 2021 & 2028
Figure 9. Pain Relief Use Case
Figure 10. Anesthesia Use Case
Figure 11. Cough Suppression Use Case
Figure 12. Diarrhea Suppression Use Case
Figure 13. Deaddiction Use Case
Figure 14. Others Use Case
Figure 15. Opioids Report Years Considered
Figure 16. Global Opioids Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Opioids Market Size 2017-2028 (US$ Million)
Figure 18. Global Opioids Sales (2017-2022) & (MT)
Figure 19. Global Opioids Market Size Market Share by Region: 2021 VS 2028
Figure 20. Global Opioids Sales Market Share by Region (2017-2022)
Figure 21. Global Opioids Sales Market Share by Region in 2021
Figure 22. Global Opioids Revenue Market Share by Region in 2017 VS 2021
Figure 23. Global Opioids Sales Share by Manufacturers in 2021
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioids Sales in 2021
Figure 25. Opioids Revenue Share by Manufacturers in 2021
Figure 26. Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 27. Global Opioids Revenue Share by Type (2017-2022)
Figure 28. Global Opioids Revenue Growth Rate by Type in 2017 & 2021
Figure 29. Global Opioids Revenue Share by Application (2017-2022)
Figure 30. Global Opioids Revenue Growth Rate by Application in 2017 & 2021
Figure 31. North America Opioids Sales Market Share by Type (2017-2028)
Figure 32. North America Opioids Revenue Market Share by Type (2017-2028)
Figure 33. North America Opioids Sales Market Share by Application (2017-2028)
Figure 34. North America Opioids Revenue Market Share by Application (2017-2028)
Figure 35. North America Opioids Sales Share by Country (2017-2028)
Figure 36. North America Opioids Revenue Share by Country (2017-2028)
Figure 37. U.S. Opioids Revenue (2017-2028) & (US$ Million)
Figure 38. Canada Opioids Revenue (2017-2028) & (US$ Million)
Figure 39. Europe Opioids Sales Market Share by Type (2017-2028)
Figure 40. Europe Opioids Revenue Market Share by Type (2017-2028)
Figure 41. Europe Opioids Sales Market Share by Application (2017-2028)
Figure 42. Europe Opioids Revenue Market Share by Application (2017-2028)
Figure 43. Europe Opioids Sales Share by Country (2017-2028)
Figure 44. Europe Opioids Revenue Share by Country (2017-2028)
Figure 45. Germany Opioids Revenue (2017-2028) & (US$ Million)
Figure 46. France Opioids Revenue (2017-2028) & (US$ Million)
Figure 47. U.K. Opioids Revenue (2017-2028) & (US$ Million)
Figure 48. Italy Opioids Revenue (2017-2028) & (US$ Million)
Figure 49. Russia Opioids Revenue (2017-2028) & (US$ Million)
Figure 50. Asia Pacific Opioids Sales Market Share by Type (2017-2028)
Figure 51. Asia Pacific Opioids Revenue Market Share by Type (2017-2028)
Figure 52. Asia Pacific Opioids Sales Market Share by Application (2017-2028)
Figure 53. Asia Pacific Opioids Revenue Market Share by Application (2017-2028)
Figure 54. Asia Pacific Opioids Sales Share by Region (2017-2028)
Figure 55. Asia Pacific Opioids Revenue Share by Region (2017-2028)
Figure 56. China Opioids Revenue (2017-2028) & (US$ Million)
Figure 57. Japan Opioids Revenue (2017-2028) & (US$ Million)
Figure 58. South Korea Opioids Revenue (2017-2028) & (US$ Million)
Figure 59. India Opioids Revenue (2017-2028) & (US$ Million)
Figure 60. Australia Opioids Revenue (2017-2028) & (US$ Million)
Figure 61. Taiwan Opioids Revenue (2017-2028) & (US$ Million)
Figure 62. Indonesia Opioids Revenue (2017-2028) & (US$ Million)
Figure 63. Thailand Opioids Revenue (2017-2028) & (US$ Million)
Figure 64. Malaysia Opioids Revenue (2017-2028) & (US$ Million)
Figure 65. Philippines Opioids Revenue (2017-2028) & (US$ Million)
Figure 66. Vietnam Opioids Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Opioids Sales Market Share by Type (2017-2028)
Figure 68. Latin America Opioids Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Opioids Sales Market Share by Application (2017-2028)
Figure 70. Latin America Opioids Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Opioids Sales Share by Country (2017-2028)
Figure 72. Latin America Opioids Revenue Share by Country (2017-2028)
Figure 73. Mexico Opioids Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Opioids Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Opioids Revenue (2017-2028) & (US$ Million)
Figure 76. Middle

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs